/** UPL FY26: Margin-led growth, deleveraging, and a platform play */

UPL FY26: Margin-led growth and deleveraging set the tone for FY27

UPL’s FY26 Capital Markets Day message was straightforward: profitable growth has to come with financial discipline. In a year when farm economics stayed under pressure because of softer commodity prices and persistent volatility across geopolitics and trade, the company reported a broad-based operating recovery and a visible clean-up in the balance sheet.

For FY26, UPL reported revenue of ₹51,839 crore, up 11 percent year on year. Management attributed the growth mix to volume up 8 percent, pricing down 3 percent, and FX adding 6 percent. The quality of the growth improved: contribution rose 17 percent and contribution margin expanded to 41.2 percent. EBITDA increased 18 percent to ₹9,588 crore, taking the EBITDA margin to 18.5 percent.

The most meaningful jump was below EBITDA. Profit before tax rose to ₹3,157 crore from ₹830 crore, supported by higher EBITDA and lower net finance costs. PATMI increased to ₹1,921 crore, while operational PATMI was reported at ₹1,860 crore, with management highlighting that FY25 had a one-off tax provision reversal that was excluded from the operational comparison.

FY26 performance snapshot and what drove it

UPL’s narrative leaned on three anchors: volume-led growth across key markets, margin expansion driven by product mix and lower input costs, and disciplined capital management.

Regionally, the company presented FY26 revenue growth across all major buckets, led by Latin America, North America, and Europe. The FY26 region numbers shown in the deck were: LATAM ₹19,358 crore, North America ₹7,182 crore, Europe ₹8,167 crore, India ₹6,343 crore, and Rest of World ₹10,789 crore.

A key feature of the FY26 story was that growth was not limited to a single geography or business line. The platform format adopted by UPL makes this easier to see. UPL Corp, the global crop protection business, remained the largest driver. Advanta continued to scale as a higher-margin seeds platform. SUPERFORM improved profitability despite a flat top line due to its cost-plus structure in parts of the portfolio and a rising contribution from specialty chemicals. UPL SAS, focused on India crop protection (proforma, excluding Nurture), held revenue flat but expanded margins.

Platform scorecard: where growth and margins came from

UPL Corp reported FY26 revenue of ₹38,277 crore, up 11 percent, with EBITDA rising 20 percent to ₹6,008 crore. Management described the growth as volume-led, with pressure on pricing structurally limiting upside in the post-patent segment. The company emphasized operational excellence, better capacity utilization, and working capital discipline as drivers of contribution margin expansion.

Innovation was positioned as a measurable lever. UPL Corp said it launched more than 300 new products in FY26, generating over $160 million of revenue from new product launches. The innovation rate was reported to have improved to about 16 percent.

UPL SAS delivered flat FY26 revenue at ₹3,212 crore, but contribution increased 19 percent to ₹1,033 crore and EBITDA increased 24 percent to ₹548 crore. Management linked this to product mix improvement and scaling of focus brands, while noting adverse monsoon conditions as a drag on revenue.

Advanta’s FY26 revenue increased 23 percent to ₹6,837 crore, with EBITDA rising 30 percent to ₹1,725 crore. The deck attributes growth to a mix of volume, pricing, and FX, with field corn highlighted as the largest crop segment at 40 percent of Advanta revenue.

SUPERFORM reported FY26 revenue of ₹10,298 crore, up 1 percent, but with contribution margin expanding 240 basis points to 24.7 percent and EBITDA margin expanding 100 basis points to 12.2 percent. The internal split provided in the presentation showed Active Ingredients (AI) revenue at ₹7,403 crore and Super Specialty Chemicals (SSC) revenue at ₹2,894 crore. SSC was reported to have grown 20 percent year on year, taking its revenue mix to 28 percent.

Balance sheet reset: what changed in FY26

The second half of the investor narrative focused on debt reduction, maturity extension, and liquidity buffers.

UPL highlighted several FY26 actions: redemption of $400 million perpetual bonds at the first call date, repayment of a$500 million loan due March 2026 using internal accruals and rights proceeds, refinancing of a $400 million loan due September 2026 by extending it to March 2029 at better pricing, and securing a$300 million committed revolving credit facility.

As a result, gross debt declined to $2,325 million and net debt fell to$1,616 million. The net debt to EBITDA ratio improved from 2.1x in FY25 to below 1.6x in FY26, beating management’s stated guidance. The deck also shows the consolidated debt profile as predominantly unsecured (99.1 percent) and largely USD denominated (97.8 percent), which remains a structural exposure in periods of currency volatility.

Working capital discipline was presented as stable despite challenging macro conditions. Net working capital days increased modestly to 57 from 53. Inventory days (DIO) moved to 89 from 81 and receivable days (DSO) increased to 116 from 102, while payable days (DPO) increased to 148 from 130.

UPL also disclosed factoring of receivables on a non-recourse basis as a risk management measure, with non-recourse receivables factoring at ₹10,231 crore as of March 31, 2026.

FY27 starts with Q1 guidance, not full-year promises

Management chose to provide guidance only for Q1 FY27, citing uncertain conditions around supply chain disruptions and geopolitical risks.

The Q1 FY27 guidance disclosed in the presentation was revenue growth of 10 to 14 percent and EBITDA growth of 14 to 18 percent. In the Q&A, the CFO indicated that FX could contribute around 7 to 9 percent to the Q1 revenue growth, while the EBITDA impact of FX would be lower than the impact on reported revenue.

On capital allocation, the CFO indicated that FY27 capex could be higher than FY26. In the transcript, the capex range discussed was roughly $300 million to$350 million (around $325 million). Management reiterated that working capital days around 65 would be a comfortable level, even though the company delivered 53 to 57 days recently.

The discussion also highlighted a conservative approach to tax and deferred tax assets. The CFO said the FY26 effective tax rate appeared higher because DTAs were not recognized on certain provisions, and guided to a tax rate of about 20 to 22 percent for next year.

Key investor watchpoints from the CMD

One, the company’s operating recovery in FY26 was supported by volume growth and margin expansion. But pricing pressure in post-patent crop protection remains a structural constraint, which management also acknowledged.

Two, credit risk is being managed more proactively, but the higher expected credit loss provisions are a reminder of the environment. The presentation flagged an ECL charge of ₹379 crore in Q4FY26, including a group-level provision of ₹350 crore as a prudent measure.

Three, the liquidity plan has become clearer. However, investors still need to track the $500 million maturity shown for December 2026, even as management said repayment is on track and additional facilities have been arranged.

Four, UPL’s platform narrative is moving toward higher-quality mix: sustainable solutions at UPL Corp, higher-margin seeds growth at Advanta, and rising specialty chemicals at SUPERFORM. Whether these shifts are enough to structurally lift returns will be a key debate as FY27 unfolds.

Overall, FY26 looked like a year where UPL balanced growth, profitability, and leverage reduction. The company enters FY27 with a stronger balance sheet, a more explicit focus on innovation-led mix improvement, and a cautious guidance stance that acknowledges the volatility in the sector.